Evidence map›Paper›PMID 22496218›Full record

ArticleJournal of virology2012

Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infection.

Christina F Thobakgale, Lena Fadda, Kimberly Lane, Ildiko Toth, Florencia Pereyra, Suzane Bazner, Thumbi Ndung'u, Bruce D Walker, Eric S Rosenberg, Galit Alter and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Phenotypic and Functional Plasticity of CXCR6Frontiers in immunology · 2021
    Article
  4. Differential Effect of Mucosal NKp44Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  5. CXCR6Frontiers in immunology · 2019
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Observational
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Christina F ThobakgaleHIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Lena Fadda
Kimberly Lane
Ildiko Toth
Florencia Pereyra
Suzane Bazner
Thumbi Ndung'u
Bruce D Walker
Eric S Rosenberg
Galit Alter
Mary Carrington
Todd M Allen
Marcus Altfeld
Harvard University · USRagon Institute of MGH, MIT and Harvard · USUniversity of KwaZulu-Natal · ZA

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Effects of genetic polymorphism in MHC, KIR, and related loci on human diseaseZIABC010791 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CARRINGTON, MARY N. · 2009 to 2025
$18.2M
Recognition of HIV-1 by Innate Immunity Receptors during Primary InfectionP01AI074415 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ALLEN, TODD M · 2008 to 2013
$17.3M
TUBERCULOSIS SUPPLEMENTD43TW000231 · FIC · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ABDOOL KARIM, QUARRAISHA · 1993 to 2014
$13.1M
NK cell mediated immune pressure in HIV-1 infectionR01AI067031 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ALTFELD, MARCUS · 2006 to 2015
$4.4M
CCR NIH HHS HHSN261200800001CFIC NIH HHS 3 D43 TW000231 16S2FIC NIH HHS D43 TW000231Intramural NIH HHSNCI NIH HHS HHSN261200800001ENIAID NIH HHS P01 AI074415NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI067031
6 · The paper itself

Abstract

Natural killer (NK) cells play a critical role in the control of HIV-1 infection, and NK cells that respond to HIV-1 peptides have been recently described. However, the mechanisms by which NK cells recognize HIV-1 antigens are not fully understood. We investigated NK cell activation in response to HIV-1 peptides during early and chronic HIV-1 clade B infection using a whole-blood assay and multiparameter flow cytometry. Antibody-mediated NK cell activation in response to HIV-1 peptides was not detected in HIV-1-uninfected individuals. In contrast, 79% of individuals with chronic infection and 22% of individuals with early infection had detectable gamma interferon (IFN-γ) NK cell responses to HIV-1 antigens (P < 0.00001). IFN-γ- and tumor necrosis factor alpha (TNF-α)-producing NK cells most frequently targeted Env gp120 (median of 4% and range of 0 to 31% of all NK cells). NK cells rarely targeted other HIV-1 proteins such as Gag, Pol, and Nef. Antibody-mediated NK cell responses to peptides mapped predominantly to Env protein, required the presence of plasma or plasma IgG, and resulted in lower CD16 expression on NK cells, suggesting an antibody-mediated activation of NK cells. Further studies are needed to assess the consequences of these antibody-mediated NK cell responses for HIV-1 disease progression and vaccine-induced protection from infection.

Indexed as

Antibodies, ViralChronic DiseaseFemaleHIV-1HIV Envelope Protein gp120HIV InfectionsHumansImmunoglobulin GInterferon-gammaKiller Cells, NaturalLymphocyte ActivationMaleAntibodies, ViralHIV Envelope Protein gp120IFNG protein, humanImmunoglobulin GInterferon-gamma

Identifiers

PMID22496218
PMCPMC3393568
OpenAlexW2128546340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.